This trend towards a higher risk of ischaemic stroke for apixaban was also observed in our sensitivity analyses for the whole cohort, although it did not reach statistical significance.
← all excerpts
Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population-based propensity-weighted cohort study.
1
—
—